| Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrimido-diazepi… | | homo-4-mer | 519-794 | 100.0 | 8×MG; 4×92M; |
|
| HUMAN MPS1 IN COMPLEX WITH NMS-P715 | | homo-2-mer | 515-795 | 100.0 | 2×SVE; |
|
| Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … | | homo-2-mer | 516-794 | 98.84 | 2×5NW; 2×DMS; |
|
| Crystal structure of TTK kinase domain | | monomer | 515-796 | 100.0 | |
|
| Crystal structure of TTK kinase domain in complex with compound 7 | | monomer | 515-795 | 100.0 | 1×FZR; |
|
| Crystal structure of human Mps1 catalytic domain in complex with the inhibitor staurosporine | | monomer | 514-794 | 100.0 | 1×7PE; 1×STU; 3×IPA; 4×GOL; |
|
| Crystal structure of TTK kinase domain in complex with compound 9 | | monomer | 515-795 | 100.0 | 1×FZL; |
|
| Human Mps1 kinase domain with ordered activation loop | | monomer | 515-795 | 100.0 | 6×GOL; 2×CL; |
|
| Crystal structure of TTK kinase domain in complex with compound 28 | | monomer | 515-795 | 100.0 | 1×G0U; |
|
| Human TTK in complex with a Dyrk1B inhibitor | | monomer | 513-793 | 99.6 | 1×DYK; |
|
| Crystal Structure of TTK kinase domain with an inhibitor: 400740 | | monomer | 515-794 | 100.0 | 4×PO4; 1×1PH; 10×EDO; |
|
| Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitor | | monomer | 516-795 | 100.0 | 1×GOL; 1×PEG; 6×EDO; 1×052; |
|
| Crystal structure of TTK kinase domain in complex with compound 30 | | monomer | 515-794 | 100.0 | 1×FZO; 2×MG; |
|
| CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridi… | | monomer | 516-795 | 100.0 | 8×IOD; 1×O22; |
|
| X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16 | | monomer | 515-794 | 100.0 | 1×NN5; |
|
| Crystal structure of the human TTK in complex with an inhibitor | | monomer | 515-794 | 100.0 | 1×KE7; 1×1PE; 1×EDO; |
|
| Crystal structure of Human MPS1 catalytic domain in complex with 5-(5-ethoxy-6-(1-methyl-1H-pyrazol… | | monomer | 516-795 | 100.0 | 1×1O5; |
|
| Crystal structure of human Mps1 catalytic domain T686A mutant in complex with SP600125 inhibitor | | monomer | 516-795 | 99.61 | 1×537; 1×7PE; |
|
| Crystal structure of TTK kinase domain in complex with compound 19 | | monomer | 516-795 | 100.0 | 1×G5C; |
|
| CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1… | | monomer | 516-795 | 100.0 | 1×IOD; 1×O38; |
|
| CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH (E)-3-(4-((6-(((3s,5s,7s)-adamanta… | | monomer | 516-795 | 100.0 | 1×O17; |
|
| Crystal structure of TTK kinase domain with an inhibitor: 401348 | | monomer | 515-793 | 100.0 | 1×1PF; 2×SO4; 2×PEG; 2×GOL; |
|
| Crystal structure of human Mps1 catalytic domain in complex with a quinazolin ligand Compound 4 | | monomer | 516-794 | 100.0 | 1×CX4; 1×7PE; 1×PEG; 3×GOL; 3×IPA; |
|
| CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-yl… | | monomer | 516-794 | 100.0 | 1×CL; 1×O23; |
|
| X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46 | | monomer | 516-794 | 100.0 | 1×O23; 1×CL; |
|
| Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]… | | monomer | 515-793 | 100.0 | 1×2QK; 1×GOL; |
|
| Crystal structure of TTK kinase domain in complex with compound 8 | | monomer | 516-794 | 100.0 | 1×FZF; |
|
| Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … | | monomer | 516-794 | 98.83 | 1×5O7; |
|
| Crystal structure of human Mps1 catalytic domain in complex with ATP | | monomer | 516-794 | 100.0 | 1×ATP; 1×7PE; |
|
| Crystal structure of human Mps1 (TTK) C604Y mutant in complex with NMS-P715 | | monomer | 519-797 | 99.63 | 1×SVE; 2×EDO; |
|
| CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrah… | | monomer | 516-794 | 100.0 | 1×O43; |
|
| TTK in Complex with Inhibitor | | monomer | 515-793 | 100.0 | 1×CQ7; 1×CAC; |
|
| Crystal structure of human mitotic checkpoint kinase Mps1 catalytic domain apo form | | monomer | 516-794 | 100.0 | 1×7PE; |
|
| X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79 | | monomer | 516-793 | 100.0 | 1×8RH; |
|
| X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 41 | | monomer | 517-794 | 100.0 | 1×8QW; 1×CL; |
|
| Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … | | monomer | 519-796 | 100.0 | 1×0SQ; |
|
| Crystal structure of human Mps1 (TTK) C604W mutant in complex with Cpd-5 | | monomer | 519-796 | 99.62 | 1×C5N; 1×EDO; |
|
| Structure of Human MPS1 (TTK) covalently bound to RMS-07 inhibitor | | monomer | 519-795 | 100.0 | 1×YB4; 5×GOL; 1×TOE; |
|
| Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. | | monomer | 519-795 | 100.0 | 1×O38; 4×GOL; 3×MG; |
|
| Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. | | monomer | 519-795 | 100.0 | 1×AU5; 2×P4C; 3×DMS; 13×EDO; |
|
| Crystal structure of human Mps1 (TTK) in complex with Cpd-5 | | monomer | 519-795 | 99.61 | 1×C5N; 12×EDO; 1×CL; |
|
| Crystal structure of human Mps1 (TTK) in complex with Reversine | | monomer | 519-795 | 99.61 | 1×AD5; 1×EDO; |
|
| Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … | | monomer | 519-794 | 100.0 | 1×5OQ; 2×DMS; |
|
| Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. | | monomer | 519-794 | 99.61 | 1×PWU; 10×EDO; 1×DMS; |
|
| TTK kinase domain in complex with TC-Mps1-12 | | monomer | 519-794 | 100.0 | 1×8QE; |
|
| Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … | | monomer | 519-794 | 100.0 | 1×5O1; 1×DMS; |
|
| Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … | | monomer | 519-794 | 100.0 | 7×7PE; 1×5O4; 5×EDO; 1×DMS; |
|
| TTK kinase domain in complex with NTRC 0066-0 | | monomer | 519-794 | 100.0 | 1×N66; 1×PGF; 1×NA; |
|
| TTK kinase domain in complex with BAY 1161909 | | monomer | 519-794 | 100.0 | 1×8QW; |
|
| Crystal structure of human dual specificity protein kinase (TTK) | | monomer | 519-794 | 100.0 | 2×7PE; |
|
| TTK kinase domain in complex with Mps-BAY2b | | monomer | 519-794 | 100.0 | 1×8Q5; 5×NA; 1×PG0; |
|
| Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 | | monomer | 519-794 | 100.0 | 3×7PE; 1×7CE; 3×EDO; |
|
| Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. | | monomer | 519-794 | 99.61 | 1×SVE; 5×EDO; 1×DMS; |
|
| Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enab… | | monomer | 519-794 | 100.0 | 1×FMW; 1×7PE; |
|
| Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 | | monomer | 519-794 | 100.0 | 1×X21; |
|
| MPS1 kinase with 3-aminopyridin-2-one inhibitors | | monomer | 519-794 | 100.0 | 1×W2K; 5×EDO; 1×DMS; |
|
| MPS1 kinase with 3-aminopyridin-2-one inhibitors | | monomer | 519-794 | 100.0 | 1×WBI; 2×DMS; 2×EDO; |
|
| TTK kinase domain in complex with MPI-0479605 | | monomer | 519-794 | 100.0 | 1×8PT; 2×7PE; |
|
| Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 | | monomer | 519-794 | 100.0 | 1×4T9; 1×1PE; 4×7PE; |
|
| Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 | | monomer | 519-794 | 100.0 | 1×7RO; 2×7PE; 2×EDO; |
|
| Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 | | monomer | 519-794 | 100.0 | 1×X20; 1×7PE; |
|
| Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. | | monomer | 519-794 | 99.6 | 4×7PE; 1×AU5; 1×DMS; 3×EDO; |
|
| Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor | | monomer | 519-794 | 100.0 | 4×7PE; 1×ZO6; 4×EDO; |
|
| Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrolo-pyridin l… | | monomer | 519-794 | 100.0 | 1×S22; 2×7PE; |
|
| TTK kinase domain in complex with BAY 1217389 | | monomer | 519-794 | 100.0 | 1×8RH; |
|
| Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. | | monomer | 519-794 | 100.0 | 1×PWU; |
|
| Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 | | monomer | 519-794 | 100.0 | 1×7RO; 1×7PE; |
|
| Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. | | monomer | 519-794 | 99.6 | 1×7RO; 1×1KA; 1×PGE; 2×EDO; |
|
| Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor | | monomer | 519-794 | 100.0 | 2×7PE; 1×Z0W; 1×EDO; |
|
| Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. | | monomer | 519-794 | 99.61 | 1×O38; 2×7PE; 2×EDO; |
|
| Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor | | monomer | 519-794 | 100.0 | 2×7PE; 1×Z0B; 1×EDO; |
|
| TTK kinase domain in complex with a PEG-linked pyrimido-indolizine | | monomer | 519-794 | 100.0 | 1×8QZ; |
|
| MPS1 kinase with 3-aminopyridin-2-one inhibitors | | monomer | 519-794 | 100.0 | 1×3D7; 4×EDO; |
|
| Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor | | monomer | 519-794 | 100.0 | 2×EDO; 1×7PE; 1×ZO8; |
|
| Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … | | monomer | 519-753 | 100.0 | 1×5OE; 3×DMS; |
|
| Crystal structure of the tetratricopeptide repeat (TPR) motif of human dual specificity protein kin… | | monomer | 59-199 | 100 | |
|
| Crystal structure of human Mps1 TPR domain | | monomer | 62-199 | 100 | 1×PG4; 2×GOL; |
|
| Crystal structure of the tetratricopeptide repeat (TPR) motif of human dual specificity protein kin… | | monomer | 59-196 | 100 | 1×PB; |
|